FDA Approves Drug for Pre-Exposure Prevention of COVID-19The U.S. Food and Drug Administration (FDA) has authorized a new drug that may help prevent COVID-19. It is called Evusheld (tixagevimab co-packaged with cilgavimab).1-3 Evusheld is not authorized for...Reactions0reactionsComments0 comments
American Cancer Society Releases 2021 Report on CancerThe American Cancer Society (ACS) has released its 2021 report on cancer, called Cancer Facts and Figures 2021. The data in this report is 2 to 4 years behind the...Reactions0reactionsComments0 comments
COVID-19 and Flu: Similarities, Differences, and How to Protect YourselfAs the coronavirus and flu season collide, this upcoming fall and winter will be like none the world has ever seen. Here in the United States, it is important to...Reactions0reactionsComments0 comments
COVID-19 Risks for People with CancerEditor’s Note: This article was first published on August 20, 2020. Further developments in what we know about the coronavirus are continuously emerging. Learn more in Advanced Breast Cancer and...Reactions0reactionsComments0 comments
COVID-19 Updates, July 16: Updates on People at Risk, Testing, Reopening, and a VaccineEven after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for...Reactions0reactionsComments0 comments
COVID-19 Updates, June 15: Solidarity Hydroxychloroquine Trials and COVID Vaccine DevelopmentMany of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments...Reactions0reactionsComments0 comments
COVID-19 Updates, May 7: Remdesivir, Antibody Testing, and Reinfection RiskOur world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people...Reactions0reactionsComments0 comments
What to Know About Cancer and COVID-19 (Coronavirus)The spread of the novel coronavirus, COVID-19, has changed our daily lives. But people with a higher risk for illness from COVID-19 are wondering what they can do to stay...Reactions0reactionsComments0 comments
FDA Makes Way For Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...Reactions0reactionsComments0 comments
COVID-19: Tips To Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to...Reactions0reactionsComments0 comments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can...Reactions0reactionsComments0 comments
The American Cancer Society Issues 2020 Report on CancerThe American Cancer Society (ACS) recently released its report, Cancer Statistics, 2020. The report found that the death rate from cancer in the US is dropping. Between 1991 and 2017...Reactions0reactionsComments0 comments
Nerlynx (neratinib) Approved For HER2-Positive MBCThe United States Food and Drug Administration (US FDA) approved Nerlynx (neratinib) for the treatment of metastatic breast cancer. Nerlynx is used in combination with the chemotherapy drug capecitabine. Specifically...Reactions0reactionsComments0 comments
FDA Recent Approval of Kanjinti (Biosimilar to Herceptin)Last month, the FDA approved Kanjinti, the 5th biosimilar to Herceptin. Kanjinti is approved for the treatment of HER2-overexpressing adjuvant and metastatic breast cancer. Kanjinti is a HER2 receptor antagonist...Reactions0reactionsComments0 comments
